Home of Hepatology7 rue Daubin1203 GenevaSwitzerland+41 22 807 03 60easloffice@easloffice.eu© 2025 EASL. All rights reserved.Website by Soto.Privacy Policy | Cookie Policy | Terms & Conditions | Cyber Security Explore offerUnlock the full potential of being part of the EASLcommunity. As a member, you’ll gain access toexclusive resources, reduced event fees, top-tierjournals, and professional development opportunitiesdesigned to support your career in hepatologyBecome a memberNurses & Allied Health ProfessionalsLink titleYoung InvestigatorsLink titleBasic ScienceLink titleTitle here Lorem ipsum At the heart of EASL is a diverse and dynamic international community of professionals dedicated to advancing hepatology.Discover how you can get involved and make an impact.Whether you're a member, a Young Investigator, a nurse or allied health professional, or focused on basic science, there's a place for you here. Explore the different pathways to connect, grow and contribute, from membership benefits to tailored programmes and scientific networksLorem ipsum dolor sit ipsum CommunitySign In / Sign UpResourcesWhat We DoAbout Us Partnerships

Healthy Livers, Healthy Lives Coalition

About

A coalition of five liver societies — EASL, AASLD, ALEH, APASL and SOLDA — coordinating global priorities on steatotic liver disease (SLD). Since its founding in 2022, HLHL has run a sustained, multi-year campaign at the World Health Assembly, building the diplomatic and evidence base that led, in May 2026, to the adoption of the first WHO resolution dedicated to steatotic liver disease. That work is now moving into implementation: through the new WHO SLD Collaborating Centre — a tripartite partnership between WHO, Imperial College London and EASL, launched in June 2026 — HLHL is working directly with national governments to translate the resolution into country-level action.

Healthy Livers Healthy Lives

Partner societies

ALEH logo
SOLDA logo

Vision and mission

Our Vision
A world free of liver diseases

Our Mission
Mobilising the evidence, partnerships and political will to act on liver disease.

Our Goal
Reducing the prevalence and burden of liver disease worldwide, with steatotic liver disease recognised and addressed as a core NCD. 

Priorities

  • Expanding effective partnerships on NCDs 
    Increasing the number of organisations and stakeholders working alongside HLHL on non-communicable disease, and setting an ambitious agenda for the years ahead. 

  • Delivering the research roadmap 
    Turning the roadmap’s priorities into practice — supporting countries and partners with the evidence and strategies needed to implement them. 

  • Advancing global advocacy 
    Building on the 2026 WHO resolution to secure liver health’s place on the global health policy agenda, working through WHO and the new SLD Collaborating Centre. 

  • Shaping Europe’s non-communicable disease policy 
    Pressing for liver disease to be explicitly integrated into EU NCD policy, closing a gap that current frameworks still leave open. 

Steering Committee members

Debbie Shawcross
United Kingdom
Ana Lleo
Italy
Saul J. Karpen
United States
Michael Lucey
United States
Jacob George
Australia
Wendy Spearman
South Africa

Projects

World Liver Day

International health days play a vital role in raising awareness for major health issues such as chronic liver diseases. World Liver Day, happening annually on 19 April, strives to promote prevention campaigns, improve screening strategies, and increase access to timely and effective treatment.

WHA Side Events

Healthy Livers, Healthy Lives Coalition convenes high-level side events alongside the World Health Assembly, bringing together policymakers, Permanent Mission representatives, WHO officials, clinical experts, patient advocates, and people affected by liver disease.

HLHL advocacy timeline

  • October 2022: Creation of the Healthy Livers Healthy Lives Coalition at Wilton Park – the first step to shaping the future of SLD advocacy  
Scroll to Top

Search EASL